LONDON (Alliance News) - Personalised medicine and biotechnology company Epistem Holdings PLC on Wednesday said three of its executives together bought over 60,000 shares in the company.
Ian Gilham, chairman and interim chief executive, bought 20,500 shares, Finance Director John Rylands bought 20,749 shares, and Chief Operating Officer Allan Brown bought 20,749 shares.
All the shares were purchased on Wednesday at 120.00 pence per share.
Epistem shares were flat at 120.00p Wednesday afternoon.
By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.